Discovery of dormancy associated antigens of Mycobacterium tuberculosis : novel targets for the development of post-exposure or therapeutic tuberculosis vaccines
Hele tekst
(2) Chapter6 Cross-reactive immunity to Mycobacterium tuberculosis DosR regulon encoded antigens in individuals infected with environmental, non-tuberculous mycobacteria ͳǡǤǤǤʹǡǤͳǡ Ǥ ͳǡǤǤǤ ͳǡǤͳǡ ǤǤͳǡ Ǥ ͵ǡ Ǥ ͳǡ ǤǤͳ .
(3) ǡ ǡͳǢ ʹ ǡ
(4) . ͵ǡ ǡǡǡ InfectImmun.2009Nov:77(11):50715079.
(5) Chapter6. Abstract Mycobacterium tuberculosis ȋM. tuberculosisȌ Ǧ M.tuberculosisǦ Ǥ Ǧ ȋȌ Ǧ M. tuberculosisǦ ǦM.tuberculosisǤ M.tuberculosisǦ Ǧ Ȁ Ǥ M. tuberculosis Ǧ Ǧ Ǥ
(6) J Ȁ M. tuberculosis Ǧ Ǥ Ǧ Ǧ ǡ Ǧ Ǥ Ǧ͵ͳ͵͵ ǦǤ M.tuberculosis Ǧ ȀǤ M.tuberculosisǦ Ǧ Ǥ. ͳʹͲ.
(7) NTMinducedresponsestoM.tuberculosisDosRantigens. Introduction ǡ ȋȌ ͳǤǤ
(8) ͻ Ǥ
(9) ǦͳȀMycobacterium tuberculosis ȋM. tuberculosisȌ Ǧ ǡ Ǧ ȋȌ ȋȌ M. tuberculosis ȋͶͳȌǤ
(10) ʹ ȋ
(11) ȌǤ ǣM.tuberculosis ǡ Ǥ
(12) M. tuberculosis ǡ M.tuberculosis ǡM. tuberculosis ȋ͵ͳ͵͵ Ȍ Ǧ M.tuberculosis ȋʹͲǡ͵ʹȌǤ in vitro ǡ ȋͶͲȌ ǡ ȋͳͻǡ ͵Ȍ Ǧ Ǥ Ǧ ȋͳͻǡ ͵ͷǦ͵ȌǤ
(13) ǡ M. tuberculosis Ǧ M. tuberculosis Ǧ
(14) ȋʹͲǡ ͵ʹȌǤ ǡ M.tuberculosis Ǧ ǡ M. tuberculosis ȋͳǡʹͳȌǤ ǡ M. tuberculosis Ǧ ȋ Ȍ
(15) JȋȌM.tuberculosis Ǥ ǡ ȋȌ M. tuberculosisǡ ȋʹͲȌǤ ǡǦ ȋȌǤ M. tuberculosis ȋM. tuberculosisǡ M. bovisǡ M. bovis ǡ Mycobacterium africanumǡ Mycobacterium microtiǡ Mycobacterium canettiȌ Mycobacterium leprae ȋͺǡ ʹͺȌǤ ǡ Ǥ ȋͷȌǤ
(16) Ǥ ǡ ǡ Ǣ . ͳʹͳ.
(17) Chapter6. Ȁ ȋʹǡǡͳͲǡʹȌǡ Ǥ ǡ Ǧ M. tuberculosis Ǧ Ǥ M.tuberculosis Ǧ Ǥ . MaterialsandMethod Studysubjects Ǧ ǣ ͺͲ Ǣ͵͵ǡM.tuberculosisǡ Ǧ Ǣ ͳʹ Ǣ ͳʹ Ǥ ȋͶȌǤ
(18) ǡ M.marinumȋαȌ Ǥ ǡ M. kansasii ȋαͷȌ ʹ ǡ Ǥǡ Ǥ
(19) ǡ Ǥ ȋαͶȌǡ ȋα͵Ȍ ȋαͷȌ Ǥ ȋȌǤ ȋʹͲȀͻͻ ͳ͵ȀͻȌ
(20) Ǥ ǡ ǡ Ȁ Ǥ
(21) Ǥ Ǥ ȋȌ Ǥ M.tuberculosisantigens ȋͳȌ ȋͳͷȌǤǡ M. tuberculosis ͵ ͵ ȋ
(22) ǡȌǤǦ Escherichia coli ʹͳȋ͵Ȍ ȋͳͷȌǤ ȋȀȌ ȋʹͳȌ ǡ Ǧ Ǥ. ͳʹʹ.
(23) NTMinducedresponsestoM.tuberculosisDosRantigens. ȋͶͻǢ
(24) ǡȌM.tuberculosisǮ ǯ ȋ͵ͳǡͶ͵ǡͶͶȌȋǤǡ
(25) ǡȌǤ Ǧ ǦͳͲ ȋͳȌǤ ǡ ȋʹͲ ͳͲ Ȍ Ǥ Lymphocytestimulationassay ȋʹͲȌǤǡ ȋͳǤͷέͳͲͷȀȌ
(26) ȋ ǡǡȌ ͳͲΨǡͷͲȀ ͷͲPȀ ǡͻǦ Ǧ ȋ ǡ ǡ Ȍ ͵qǡ ͷΨ ʹǡ ȋ ȌǤ ǣM.tuberculosis ͲǤ͵͵Pȋ ͺρȀǡͶǤ͵ǦͳǤʹȌǡM.tuberculosis ͷPȀ Ǧ ǦͳͲͳPȀ Ǥ ȋ Ǣ ǡ ǡ ʹ PȀȌ ǤǡȂʹͲǤ DetectionofIFNJJbyELISA
(27) J
(28) ȋǦ ǡ ǡ Ȍ ȋʹͲȌǤ ʹͲȀǤ ȋ ʹͲ Ȁǡ ʹͲǦͳͺͶȌ Ǥ tͳͲͲȀǤ AssessmentofDosRproteinorthologsinenvironmental(myco)bacteria. Ǥ Ǥ ǡM. tuberculosis Ǧ Ǥ
(29) ȋ
(30) Ȍ ȋ͵ͲȌ Ǥ ȋȌ ȋͳȌǡ M.tuberculosisǦ ȋ Ȍ ǦǤ M.tuberculosisǦ Ǥ ǡ Ǥ Ǧ ͶͲΨ Ǥ Statisticalanalysis ȋȌ Ǥ ȋ PǦαͳǦȋͳǦPȌȌǦ ǤǦ Ǧ Ǥ ȋǤǤ . ͳʹ͵.
(31) Chapter6. ȌǤ ͳͶǤͲ ͶǤͲʹǢPδͲǤͲͷ Ǥ . Results SelectionofM.tuberculosisDosRregulonencodedantigens M. tuberculosis Ǧ ȋͳȌǤ Ǧ ǡ Ǧ ȋ Ȍ ȋʹͲȌǣ ͳ͵͵ ǡ ʹͲʹͻ ǡ ʹͲ͵ʹǡ ʹʹ ǡ ͵ͳʹͻ ͳͲ Ǥ ʹʹ ʹʹͺ ͳͲ ǡ Ǥ ʹͲ͵ͳ ȋͳ Ǧ ǡ ǡ Ǧ ȌȋͶʹȌ Ǧ Ǥ ǡ ȋͳʹǤ͵ǦͶǤ͵ȌǤ Table1.SelectedM.tuberculosis DosR antigenstestedinpresentstudy ͳ͵͵ ʹͲʹͻ ʹͲ͵ͳ ʹͲ͵ʹ ʹʹ ʹʹ ʹʹͺ ͵ͳʹͻ a. a a ȋȌ pfkB hspX acg. ʹʹǤͶ ͵ͷǤͶ ͳǤ͵ ͵Ǥ ͳͷǤͷ ͶǤ͵ ͳ͵Ǥͳ ͳʹǤ͵. a. . ȋǦ Ȍ . ʹͲǡʹͳǡ͵ʹ ʹͲǡʹͳǡ͵ʹ ͳͳǡͳǡʹͲǡʹͳǡ͵ʹǡͶʹǦͶͶ ͳͶǡʹͲǡʹͻǡ͵ʹ ǡʹͲǡʹͳǡ͵ͳǡ͵ʹǡ͵ ʹͲǡʹͳǡ͵ʹ ʹͲǡʹͳǡ͵ʹ ʹͲ. Annotationsarefromwww.tbdb.organdhttp://genolist.pasteur.fr/TubercuList/. InvitroPPDresponsesinhealthyindividuals:asurveyamongsthealthyM. tuberculosisunexposeddonors. ǡ ǡ ȋ͵ͻȌǤ ǡȀ ǤǡM.tuberculosisǦ Ǧ ǡ Ǥ M. tuberculosis Ȁǡ ȋαʹȌǤ ȋ ǦȌǤ ǡ ȋαȌ ȋǦȌǤ Ȁ Ǥ ǡ ǡ . ͳʹͶ.
(32) NTMinducedresponsestoM.tuberculosisDosRantigens. Figure1.ResultsofaninvitroPPDsurveyinhealthyindividualsandNTMinfected/exposedindividuals. Healthy controls were either a group of well defined healthy, M. tuberculosisuninfected, nonBCG vaccinated individuals (n=27) or a group of random healthy blood bank donors (n=66). IFNJ responses to PPD were measuredasanindicationofexposuretomycobacteria.Inboththehealthycontrolandthehealthybloodbank donorgroups,overhalfortheindividuals,56%and68%respectively,responded(IFN J>100pg/ml)toPPD. TheproportionsofPPDrespondersintheNTMinfected(n=12)orexposed(n=12)individualswereboth75%, andwereslightlyhighercomparedtothehealthycontrolgroups.Horizontalbarsshowmedianvalues. ǡ Ǥ ͳ
(33) J Ǥ
(34) ǡ ǡ ͷΨ ͺΨ ǡ ȋ
(35) JεͳͲͲȀȌǤ ǡ Ǥ ȀȋͳͺȀʹͶ ǦǢȌǡͷΨǤ
(36) ǡ Ǧ Ǥ Table2.CharacteristicsofNTMinfectedorexposedstudysubjectsincludedinthisstudy M.marinum M.kansasii . . ǡǤȀ Ǥ. ǡ ȋȌ. ͷ. Ȁͳ ͶȀͳ. ͷͺǤ͵ȋͶ͵ǤͳǦͶǤͺȌ ͷͶǤȋͶͲǤͷǦǤͶȌ. a . ͳȀ ͲȀͷ. Ͳ Ͳ. b . b. ǡ ȋȌ a b. Ͷ ͵ ͷ. ͵Ȁͳ ͵ȀͲ ͷȀͲ. ͷͶǤͶȋͶͲǤǦʹǤ͵Ȍ ͵ͺǤͻȋ͵ͶǤǦͶͳǤȌ ͶǤȋʹͺǤ͵ǦͷǤͶȌ. ͲȀͶ ͲȀ͵ ͲȀͷ. Ͳ Ͳ Ͳ. ͵ͲǤͷȋͳͲǦͶͲȌ ͳͳȋͺǦ͵ͲȌ ͵ͺȋͳͷǦͶͶȌ. ǡ ǡǡ Ǥ ǡM.marinum M.kansasii Ǥ. . ͳʹͷ.
(37) Chapter6 A. NTM exposed/infected individuals. B PPD negative controls Figure 2. IFNJ responses to M. tuberculosis antigens in NTM primed individuals and in healthy, PPD )individuals.ResponsestoM.tuberculosisantigens:Mtblysate,Ag85B,ESAT6,CFP10,anda negative(PPD seriesofeightDosRregulonencodedantigensweremeasuredinindividualsinfectedwith,orexposedintensely to environmental mycobacteria (n=2417). Significant IFNJ production was measured in the NTM primed individuals (A). Also responses to different batches of recombinant M. tuberculosis antigens Ag85B, ESAT6, CFP10 and eight DosRregulon encoded antigens were tested in different PPD individuals (maximally 20 different PPD individuals). No or low (statistically nonsignificant) responses to the various recombinant M. individuals(B).Thepercentageofrespondersisindicatedabove tuberculosisantigenswereobservedinPPD each column for each antigen. The Wilcoxon signed rank test was used for comparison of the height of the antigenic response to the negative control (medium) condition in (A). IFNJ responses t100 pg/ml were consideredpositive.Horizontalbarsrepresentmedianvalues.PHA,phytohaemagglutenin;Mtblysate,lysateof M.tuberculosisculturedunderlowoxygencondition.***,P<0.0001;**,P<0.01;*,P<0.05;ns,notsignificant.P <0.05wasconsideredstatisticallysignificant. InvitroIFNJJresponsestoselectedM.tuberculosisDosRregulonencoded antigensinindividualsinfectedwithorexposedtoenvironmentalmycobacteria ʹͶ ȋαͳʹȌ ȋαͳʹȌ ȋ ʹȌǤ ʹͶ ͺͷǡ ʹʹ ǡ ʹͲ͵ʹ ǦͳͲ ȋ αʹ͵Ȍǡ ͵ͳʹͻ. ͳʹ.
(38) NTMinducedresponsestoM.tuberculosisDosRantigens. ȋαͳȌǡ Ǥ Ǧ ȋͳ͵͵ ǡ PαͲǤͲͲʹǢ ʹͲʹͻ ǡ PαͲǤͲͳͳǢʹͲ͵ʹǡPαͲǤͲ͵ͶͳǢʹʹ ǡPαͲǤͲʹʹʹʹ ǡPαͲǤͲͲʹͷǢ Ȍǡ ʹǤ Ǥ Ǣ Ǥǡ M. tuberculosis Ǧ ǣ ͳ͵͵ ȋPα ͲǤͲ͵͵Ȍʹʹ ȋPαͲǤͲ͵ʹȌǤ ͳ͵͵ ȋͶʹΨ Ȍǡ ͺΨ ʹͲ͵ͳ ȋ ȋʹͲȌȌǤ ͺͷ ȋͶ͵ΨȌǡ ǦȋʹͷΨȌ ǦͳͲȋ͵ͷΨȌǤǦ ǦͳͲ M. tuberculosis Ǥ ǡ M. tuberculosis ǡ ͷΨ ͵Ψǡ Ǥ
(39) ǡM.tuberculosisǦ ȋǦ Ȍ Ǧ andȋ ʹȌM.tuberculosis Ǧ ȋʹͲȌ M. tuberculosis Ǧ Ǥ ǡ ǡ ǡ
(40) J M.tuberculosisǦ Ǥ M.tuberculosis M. tuberculosis ǡ ȀǤ IFNJJresponsestoM.tuberculosisDosRregulonencodedantigensinindividual groupswithspecificNTMinfectionorexposure
(41) ǡ Ȁ Ǥ ǡ ǡ ǣ ͵
(42) J ǡ ͺͷǡ Ǧǡ ǦͳͲ M. tuberculosis Ǧ ͳ͵͵ ǡ ʹͲʹͻ ǡ ʹʹ ʹʹ M.marinumȋαȌǡM.kansasiiȋαͷȌ ȋαͳʹȌǤ Ǧ ǦͳͲ M. kansasii Ǥ ǦͳͲ M.marinum ȋPδͲǤͲͷȌǡȋͶȌǤ ǡM.tuberculosisǦ Ǥ ʹͲʹͻ ʹʹ . . ͳʹ.
(43) Chapter6. . Figure 3. IFNJ responses to M. tuberculosis antigens PPD, Ag85B, ESAT6, CFP10 and M. tuberculosis DosR regulon encoded antigens Rv1733c, Rv2029c, Rv2626c and Rv2627c in individuals infected with M. marinum (n=7); M. kansasii (n=5); or intensely exposed to environmental mycobacteria (aquarium owners, flower growersandveterinarians,n=12(n=11inthecaseofCFP10,Ag85B,Rv2626c)).Horizontalbarsrepresent median values. As indicated earlier, IFNJ responses t100 pg/ml were considered positive. Statistical analysis wasperformedwiththeKruskalWallistest.IfP<0.05,analysiswascontinuedbyperformingDunn’sposthoc test,*,P<0.05,**,P<0.01.P<0.05wasconsideredstatisticallysignificant.. ThepresenceofM.tuberculosisDosRregulonproteinorthologsin environmental(myco)bacteria Ǧ ͶͺM.tuberculosis ͵Ǧ Ǥ M. tuberculosis ȋͳͷͷͳǡ Ǯǯǡ Ǯ ͳͳǯ Ǯ ǯȌǡ ǡ ǦM. tuberculosis ȋM. bovisǡ M. bovis M. lepraeȌǡ ȋǤǤ M. marinumȌ ȋȌ ȋǤǤ Streptomyces sppȌ Ǥ͵Ǥ Ǥ ǡ M. tuberculosis Ǧ M. tuberculosis ǣ ͳͲͲΨ Ǧ ͻͻΨǤ
(44) ǡM.lepraeȀ M.tuberculosisǦ ǡ Ǧ ȋͻȌǤ ǡ M. leprae ǡ M. tuberculosis ǦǦ ǡ ͲͶͶͲȋ ͷǢͻΨȌ͵ͺͲͶȋͺͷǢͻͲΨȌǤM.bovis M. bovis Ͷͺ M. tuberculosis Ǧ ȋͻͺΨǦͳͲͲΨȌǤǦǦ ǡ ͳͲǤͶ ȋͲʹͺͺȌǡ ͷ ȋͲͶͶͲȌǡ ͺͷ ȋͳͺͺ Ȍǡ ͳͲǤ͵ ȋ͵Ͳͳͻ Ȍǡ ͺͷ ȋ͵ͺͲͶ Ȍ Ǧ ȋ͵ͺͷȌǡ . ͳʹͺ.
(45) NTMinducedresponsestoM.tuberculosisDosRantigens Table3(part1).AnalysisoforthologsorhomologsofMycobacteriumtuberculosis H37Rv DosRencodedantigensintuberculousmycobacteriaandM.leprae. ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͻͺ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ʹȗ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ. yc ob. ͲͲͻ ͲͲͺͲ ͲͲͺͳ Ͳͷͻ ͲͷͲ Ͳͷͳ Ͳͷʹ Ͳͷ͵ ͲͷͶ ͳ͵͵ ͳ͵Ͷ ͳ͵ͷ ͳ͵ ͳ͵ ͳ͵ͺ ͳͺͳʹ ͳͺͳ͵ ͳͻͻ ͳͻͻ ͳͻͻͺ ʹͲͲ͵ ʹͲͲͶ ʹͲͲͷ ʹͲͲ ʹͲͲ ʹͲʹͺ ʹͲʹͻ ʹͲ͵Ͳ ʹͲ͵ͳ ʹͲ͵ʹ ʹʹ͵ ʹʹͶ ʹʹͷ ʹʹ ʹʹ ʹʹͺ ʹʹͻ ʹ͵Ͳ ʹ͵ͳ ͵ͳʹ ͵ͳʹ ͵ͳʹͺ ͵ͳʹͻ ͵ͳ͵Ͳ ͵ͳ͵ͳ ͵ͳ͵ʹ ͵ͳ͵͵ ͵ͳ͵Ͷ . M. H37RvDosRantigens. M. yc ob. ac te ri u m tu be ac rc te ul ri u M os yc m is ob tu C be ac D rc C te 15 u r M iu lo 51 yc m si s ob tu st be ac r ai rc te n ul ri u M "C os yc m " is ob tu F1 be ac 1 r te cu ri u M lo yc m si s ob bo (H ac vi aa s te AF rle ri u m 21 m ) 22 bo /9 M vi s 7 yc BC ob G ac st te r. ri u Pa m st le eu pr ae r1 17 TN 3P 2. Ψ ͵a . ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͻͺ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͷȗ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ. ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ. ͳͲͲ ͳͲͲ ͳͲͲ ͳȗ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͻ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ. ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͻͻ ͻͻ ͻͺ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͻͺ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ. ͳͲͲ ͻͺ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͻͻ ͳͲͲ ͻͻ ͻͻ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ. ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ. ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ. ͳͲͲ ͳͲͲ ͳͲͲ ͻͲȗ ͳͲͲ ͳͲͲ. ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ. ͳͲͲ ͳͲͲ ͻͻ ͳͲͲ ͳͲͲ. Ͷȗ. Ͷ͵ȗ Ͷȗ. Ͷͺȗ. ȗ. ͶͶ. ͵Ǧ ͲʹͺͺȋesxH ȀͳͲǤͶȌ ͲͶͶͲȋgroEL2 Ȁ ͷǤʹȌ ͳͺͺ ȋfbpB/ ͺͷȌ ͵Ͳͳͻ ȋesxR ȀͳͲǤ͵Ȍ ͵ͺͲͶ ȋfbpA ȀͺͷȌ ͵ͺͷȋesxA ȀǦȌ. ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ ͳͲͲ. ͺͷ ͻ ͺͺ ͺʹ ͺͻ ͷ. a. ȋ ȗȌ Ǥ ͶͲΨǤ. . ͳʹͻ.
(46) Chapter6 Table3(part2).AnalysisoforthologsorhomologsofMycobacteriumtuberculosis H37RvDosR encodedantigensinNTM.. H37RvDosRantigens ͲͲͻ ͲͲͺͲ ͲͲͺͳ Ͳͷͻ ͲͷͲ Ͳͷͳ Ͳͷʹ Ͳͷ͵ ͲͷͶ ͳ͵͵ ͳ͵Ͷ ͳ͵ͷ ͳ͵ ͳ͵ ͳ͵ͺ ͳͺͳʹ ͳͺͳ͵ ͳͻͻ ͳͻͻ ͳͻͻͺ ʹͲͲ͵ ʹͲͲͶ ʹͲͲͷ ʹͲͲ ʹͲͲ ʹͲʹͺ ʹͲʹͻ ʹͲ͵Ͳ ʹͲ͵ͳ ʹͲ͵ʹ ʹʹ͵ ʹʹͶ ʹʹͷ ʹʹ ʹʹ ʹʹͺ ʹʹͻ ʹ͵Ͳ ʹ͵ͳ ͵ͳʹ ͵ͳʹ ͵ͳʹͺ ͵ͳʹͻ ͵ͳ͵Ͳ ͵ͳ͵ͳ ͵ͳ͵ʹ ͵ͳ͵͵ ͵ͳ͵Ͷ . M yc ob ac te r iu M yc m ob sp ac .K te M r M S iu yc m ob av ac iu m te r iu 10 M yc m 4 ob m ar ac i n te um r iu M yc m M ul st oba ce r. c ra K1 ter ns 0 ium Ag M yc av y9 ob iu 9 m ac su te r iu bs M yc m p. ob sp pa ac .M ra te tu C riu be M S yc m rc ul ob sm os ac e is gm te r iu a tis m va st r nb .M aa C 2 le ni 15 iP 5 YR -1. Ψ ͵a ȋȌ. ͷͶ ͷ ͻ ͺͺ ͺ ʹȗ. ͵ ͷͷȗ ͺ. ͳ ͷͷȗ. ͺ Ͷʹȗ Ͳȗ. Ͷͳȗ ͺ. Ͷͳȗ . ͷͷȗ. ͷ͵ȗ. ͷȗ. ͷ͵. ͷ. ͷʹ. ͺ ͺͺ. Ͷͳȗ. Ͷ. Ͷʹ. Ͷͳȗ ͷȗ ͺ͵ ͺ Ͷͻ. ͺʹ Ͷͻ ͵ Ͳȗ ʹ ͺͺ Ͳ Ͷ ͺ ͵ ͳ ͺ. ͺͲ. ʹȗ Ͷͻȗ. ͻ ͷȗ ͺ͵ Ͷʹ ͵ȗ ͷͻȗ ͷ. Ͷʹȗ Ͳȗ. ͷͶ ͷ ͻ ͺ ͺ ʹȗ. ͷͳ ͷ ͳȗ Ͷʹȗ ͷȗ. ͷ͵ȗ. ͷͷȗ. ͷȗ. ͺͺ ͺʹ ͺͶ ͷͶȗ. ͷ͵. ͷͺ. Ͷͻ. ͺ ͺͺ. ͺ ͺͺ. ͷȗ ͶͲȗ ͵ȗ ͺ͵ ȗ ͺ Ͷͻ. Ͷʹ. Ͷ. ͶͶ. ͺͻ ͻͲ Ͷ. ȗ Ͷͻȗ. ȗ ͺʹ Ͷͻ. ͷȗ ʹ Ͷͻ. ͵ȗ ʹ ͷͲ. Ͷͺ ͺͲ ȗ ͺ͵ ͷͻȗ. ͵ Ͳȗ ʹ ͺͺ Ͳ Ͷ ͺ Ͷȗ ͵ ͳ ͺ. ͺ ͷȗ ͵ ͺͲ ͳ ͷȗ ͺ ͷ ͺȗ Ͳ. ͺͲ. Ͷȗ. ȗ Ͷ ͺ͵ ͳ ͺͷ ͺͳ ʹ Ͳ ͳ ͻ ͺͶ ͻ ͻ ͷ. ͷ ͺ ͳ ͺͷ ͷȗ ͻ ͺͻ ͺ ͺȗ ͺ ͺͶ ͺ Ͳ ͺͶ. ȗ ͺ ͷͷȗ ͺ Ͳ ͶͶȗ. ͺͳ. ͺͳ. Ͷ Ͳ . ͺ ͻȗ ͻ ͷȗ ͷͺȗ. ͷ͵ ͷʹȗ ͺ. ͵ȗ ͷͻȗ ͳȗ ͷͺȗ. . Ͷ Ͳ . . ͷʹȗ. ͺͳ. ͺͳ. ͷȗ. . . ͵ ͳ ͺ ͻʹ ͷͷȗ. ͺͲ ͷȗ ͷ ȗ ͻͶ . ͺͲ ͺ ͺ͵ ͺͻ ͻͷ ͻ. ͺͲ ͻ ͺʹ ͺͻ ͻͷ ͺ. ͺͲ ͷȗ ͵ ͻͶ . ͵ ͳ ͻʹ ͷͻȗ. ͳ ͺͲȗ ͻͶ ͷͶȗ. ȗ ͷͲȗ ͻ ȗ ͻͶ ͷͷȗ. ͺ ͻͷ ͺͲ ͺȗ ͺͲ Ͷ. ͺͻȗ ͻ ͻʹ ͻͳ ͺͻ. ͻ͵ȗ ͻ ͻͶ ͻͶ ͻͲ ͻ. ͻʹȗ ͻ ͻͶ ͻ͵ ͻͲ. ͺͻȗ ͻ ͻʹ ͻͳ ͺͻ. ͺ ͻͷ ͺͲ ͺȗ ͺͲ Ͷ. ͺͷ ͻͷ ͺʹ ͺͷȗ ͺͲ ͺͲ. ͺͷ ͻͷ ͺ͵ ͺͳȗ ͺ͵ȗ ͷͺ. . ͵Ǧ ͲʹͺͺȋesxH ȀͳͲǤͶȌ ͲͶͶͲȋgroEL2 Ȁ ͷǤʹȌ ͳͺͺ ȋfbpB/ ͺͷȌ ͵Ͳͳͻ ȋesxR ȀͳͲǤ͵Ȍ ͵ͺͲͶ ȋfbpA ȀͺͷȌ ͵ͺͷȋesxA ȀǦȌ a. ȋ ȗȌ Ǥ ͶͲΨǤ. . ͳ͵Ͳ.
(47) NTMinducedresponsestoM.tuberculosisDosRantigens Table3(part3).AnalysisoforthologsorhomologsofMycobacteriumtuberculosis H37RvDosRencodedantigensinenvironmentalbacteria. a. ͷʹ. ͷ ͻ. C. om yc e. St re pt. H37RvDosRantigens ͲͲͻ ͲͲͺͲ ͲͲͺͳ Ͳͷͻ ͲͷͲ Ͳͷͳ Ͳͷʹ Ͳͷ͵ ͲͷͶ ͳ͵͵ ͳ͵Ͷ ͳ͵ͷ ͳ͵ ͳ͵ ͳ͵ͺ ͳͺͳʹ ͳͺͳ͵ ͳͻͻ ͳͻͻ ͳͻͻͺ ʹͲͲ͵ ʹͲͲͶ ʹͲͲͷ ʹͲͲ ʹͲͲ ʹͲʹͺ ʹͲʹͻ ʹͲ͵Ͳ ʹͲ͵ͳ ʹͲ͵ʹ ʹʹ͵ ʹʹͶ ʹʹͷ ʹʹ ʹʹ ʹʹͺ ʹʹͻ ʹ͵Ͳ ʹ͵ͳ ͵ͳʹ ͵ͳʹ ͵ͳʹͺ ͵ͳʹͻ ͵ͳ͵Ͳ ͵ͳ͵ͳ ͵ͳ͵ʹ ͵ͳ͵͵ ͵ͳ͵Ͷ . St re pt. om yc e. s. av er m iti lis s or M c yn Aoe eb 46 lic ac ol 80 o t C er rA or iu 3( yn m 2) eb di ph ac th te C er riu or ia yn m e eb ef N f C ac ici TC t en C er or s i 13 um yn YS 12 eb gl 9 31 ut ac am 4 te R riu ho ic u m do m je co AT ik cc ei C us R um C ho 13 sp K do 03 .R 41 ba 2 1 H ct A er 1 N oc sp ar h a di er a oi fa de Pr rc s in op 2. i c io a 4. ni IF 1 ba M ct Ac 1 er 01 id i um 52 ot he D ac rm N ne A us Bi s fid KP ce ob llu A1 ac lo 71 te ly 20 tic riu us 2 m lo 11 ng B um N C C 27 05. Ψ ͵ ȋǦ Ȍ. ͷ ͺ . ͳ. ͷ. ͷ͵ Ͳȗ. ͷ͵. Ͷͳȗ. ͶͲȗ. Ͷͳȗ. Ͷͳȗ. Ͷͳȗ . ͷȗ Ͷͷ Ͷ͵. ͵ Ͷʹ Ͷ. ͷͷȗ. ͷͶȗ. ͷ͵ȗ. ͷͶȗ. ͷʹȗ ͷͳ. ͷ. Ͷͳȗ ͵. ͷͶ. ͷͷ ʹ. ͶͲȗ. ͷʹȗ. ͷ͵ȗ. ͷͷȗ Ͷʹ. ͷͷȗ Ͷʹ. ͳ ͶͲȗ. ͶͲȗ. ͺͲ ͷͳ. Ͷͷȗ. Ͷ͵. Ͷȗ. Ͷȗ. Ͳ. ͳȗ ͷͳȗ Ͷͺ. ͶͶȗ Ͷͻȗ. Ͷͺȗ. Ͷ͵. Ͷ Ͷ͵ȗ ͷ͵ȗ Ͷͷ. ʹ ʹ. ʹ Ͷͻ. ʹ Ͷͻ. Ͷ ͶͲȗ. Ͷͷ. Ͷͷȗ. Ͷȗ. Ͷͷȗ. Ͷʹȗ. Ͷͺȗ Ͷͺȗ Ͳ. Ͷͻȗ Ͷͻȗ ͷ. ͷʹ ͷʹȗ. ͷȗ ͷͺ. ͷͷȗ ͷ Ͷʹ. ͷȗ ͷ͵ȗ. Ͷ͵ȗ ͻ Ͳȗ ͷ͵ ͷͳ. Ͷͳȗ ͷͺ. ͷͳ ͷͲ ȗ Ͷʹȗ Ͷͺ Ͳȗ. ͷ ͷͲȗ ͵ ͷȗ ͶͲȗ ͷͲ. Ͷȗ Ͷʹȗ ͶͶ Ͷ. Ͷȗ Ͷͺȗ ͷͳȗ Ͷͷ ͷ. ͶͶ. Ͷͷ. ͷͻȗ ͺȗ ͶͲȗ Ͷͺ. ͷͷȗ Ͷ͵ȗ. ͷͻ ʹ ͺͲȗ Ͷͳȗ ͷͲ. ͷȗ Ͷ͵ȗ. ͷͺ ͺͲȗ Ͷͳȗ ͷͲ. ͷȗ Ͷ͵ȗ. ͷͶȗ ͶͶȗ ͺȗ Ͷʹȗ. ͷͺ Ͷ͵ȗ. ͳ ʹ ʹ Ͳ Ͷȗ ͳ ͳȗ. Ͷ. ȗ ͷͶ. ͷͻ Ͳȗ Ͷͺȗ. ͷͻ ͷͻȗ Ͷͷȗ. Ͷͺ ͺͷ. ͵ȗ. ͷͺȗ ʹ ͶͶȗ ͷͲ Ͷͷ. Ͷͻȗ Ͷ͵ȗ. ͷͲ ͶͶ. Ͷͷ. Ͷ. ͶͶȗ ͷͺ. ͷȗ ͺͲ ͶͲȗ. Ͷ Ͷȗ ͺȗ Ͷͳȗ ͷͲ. Ͳ. Ͷ. Ͷȗ. ͵ ͳ ʹȗ Ͷ͵ȗ ͷͲ Ͳȗ. ͷ. ͶͶ. Ͷͷ. ͷ. ͷȗ. ͳ ͷͳ Ͷ ͺ Ͷͷȗ. ͷͳȗ ͵ Ͳȗ ͺͷ Ͷȗ. ͷͺ. . Ͷͷȗ Ͷ Ͷȗ ͺͲ ͶͶȗ. Ͷͺȗ Ͳ Ͷͳȗ. ʹ Ͷʹȗ. ͷͺ Ͷʹȗ. Ͷ ͷͺ Ͷʹȗ. ͺͻ Ͷʹȗ. ͺͺ ͷͲȗ. ͺͻ ͷ͵. ͺͻ ͷͳȗ. ͺͻ Ͷȗ. ͻ͵ ͷͷ. Ͷʹȗ. ͷͳ Ͳȗ. ͷ͵ȗ ͷͷȗ. ͷ͵ ͷͷȗ. ͷ ͷ. ͷȗ. Ͷͻ. Ͷ͵ȗ ͷ͵ȗ ͳ Ͷ͵ȗ. ʹ . ͵. ͺ. ͻͲ. ͺͶ. ͵Ǧ ͲʹͺͺȋesxH ȀͳͲǤͶȌ ͲͶͶͲȋgroEL2 Ȁ ͷǤʹȌ ͳͺͺ ȋfbpB/ ͺͷȌ ͵Ͳͳͻ ȋesxR ȀͳͲǤ͵Ȍ ͵ͺͲͶ ȋfbpA ȀͺͷȌ ͵ͺͷȋesxA ȀǦȌ. ͻͲ. . ͻͶ ͷ͵ȗ ͷͲȗ. a. ȋ ȗȌ Ǥ ͶͲΨǤ. . ͳ͵ͳ.
(48) Chapter6. Ǥ ǡ Ǥ ͳͲǤ͵ Ǧ ǣͳͲǤ͵M.lepraeǡ ǡǦM.bovis Ǥ ǦͶͺM.tuberculosisǦ ȋ Ȍ Ǥ Ȁ ʹ Ȁ M. avium ͵ͻ Mycobacterium vanbaaleniiǤ
(49) ǡ Ǧ Ǥ Ǥ ǡ M. kansasii ͵Ǥ ǡ
(50) ͳ͵ M. tuberculosis Ȁ ȋ ͵ΨǦͺͶΨȌ M. kansasiiǡ ʹʹ ȋͺͲΨ Ȍ Ǥ M.tuberculosis Ǧ Streptomyces coelicolor ȋ Ȍ Bifidobacterium longum ȋ ȌǤ Ǧ ǡ ȋ͵Ǥͺ Ȍ Ǧ ȋʹǤͷ ͳʹ Ǧ ȌǤ
(51) ǡ Ǧ ǡ hsp65ȋͲͶͶͲȌǤ M. tuberculosis ȋ͵ͳ͵͵ Ȍ ǣ ǡ M. leprae Ǥ ͵ͳ͵͵ ȋ ͻ͵ΨȂ ͳͲͲΨȌǢ ǡǦ ȋͷͲΨǦͺΨȌǤ ǡ M. tuberculosis Ǧ Ǧ ǡ ͵ͳ͵͵ Ǥ . Discussion Ǧ M. tuberculosis ǡ M. tuberculosis Ǧ Ǥ ǡM.tuberculosis ȋ Ȍ. ͳ͵ʹ.
(52) NTMinducedresponsestoM.tuberculosisDosRantigens. M.tuberculosisǦ ȋͳͳǡʹͲǡ͵ʹȌǡ M. tuberculosis ȋʹͲǡ ͵ʹȌǤ ǡ ǡ M. tuberculosis ǡ M.tuberculosisǦ ǡM.tuberculosisǦ ȋʹͲȌ ȋʹͳȌǤ ǡ Ǧ M.tuberculosisǦ Ǥ ǡ Ǧ M. tuberculosis ȋ ʹȌǤ ǡ Ȁ M. tuberculosis Ȁ M. tuberculosis Ǥ ǡ M. tuberculosis Ǧ Ǧ ȋ ͵Ȍ Ǧ M. tuberculosisǦ Ǥ M. kansasii, M. smegmatis M. avium ȋ͵ǡ ʹ͵ǡ ͵ͺȌǤ M. smegmatis M. tuberculosis ȋͳʹȌ M. tuberculosis ʹͲ͵ͳ ȋDǦ ǡ Ȍǡ ͵ͳ͵ʹ ǡ ͵ͳ͵͵ ȋDosR, devRȌ ͵ͳ͵Ͷ ȋʹʹǡ ʹͶȌǤ
(53) ǡ M. bovis M.tuberculosisǦ Ǧ ʹͲ͵ͳ ǡ ͵ͳ͵͵ ǡ ʹʹ͵ ʹʹ ȋȌǡ M.bovis M. tuberculosis ͳ͵ ͳ͵ ȋͳͺȌǤ
(54) J ȀM.tuberculosis ǡ M. tuberculosis Ǧ ǡ Ǥ Ȁȋ ʹ͵ȌǤ ǡ ǡ Ǥ M. tuberculosis ͵ Ǧ ȋ ǡ Ȍ ȋ ͵ȌǤ M.tuberculosisǦ Ǥ ǡ ȋ Ǧ Ȍ M.tuberculosis Ǥ Ͷͳ Ͷͺ M. tuberculosis Ǧ Ǥ ǡ nonǦ M. tuberculosisǦ Ǥǡ ǡ ͵ͳ͵͵ ǡ ȋ M. lepraeǡ ȋͻȌȌǤ ͵ͳ͵͵ M.tuberculosisȋͳͶǡʹǡ͵͵ǡ ͳ͵͵.
(55) Chapter6. ͵Ͷǡ ͵ͻȌǤ ͵ͳ͵͵ Ǧ ǡ MycobacteriumǤ
(56) ǡ M.kansasiiM.marinum Ǥ ǡ ǤM.avium ǡ M. avium M. avium Ǧ ȋͷȌǤ ǡM.avium Ǥ M.marinumM.kansasii ͳ͵͵ ʹʹ M.marinumM.tuberculosis ȋͷʹǤ͵Ψ ͺͶǤͷΨ ȌǤ
(57) ǡ ʹͲʹͻ ǡ ʹʹ ȋ ͵Ȍ ʹͲ͵ʹ ȋ Ȍ ȋʹͻȌ M.marinumǤ M. tuberculosis Ǧ ͳ͵͵ ǡ ʹͲʹͻ ǡ ʹʹ ǡ ʹʹ Ǥ Ǥ Ǥ ǡ ǡ Ǥ ǡ Ǧ Ȁ Ǥ
(58) ǡ Ǥ
(59) ǡ Ǧ ȋ
(60) JȌM.tuberculosisǦ ǡ M.tuberculosis ǡM.tuberculosis Ǥ M. tuberculosis Ǧ Ǧ Ǥ M.tuberculosis Ǧ Ǥ M. tuberculosisǡ ȋͳ͵ǡ ʹͷǡ ʹȌǤ Ǧ M. tuberculosisǡ Ǥ . ͳ͵Ͷ.
(61) NTMinducedresponsestoM.tuberculosisDosRantigens. Acknowledgements ǡ ǡ Ǥ ǦǦ ʹͲͲ͵ǦͷͲ͵͵ ȋ ǯ Ȍ ǡ ȋ ͓Ͷǡ ͳʹ͓ͺʹȌǤ ǦǦ ǦͳͲǤ. ͳ͵ͷ.
GERELATEERDE DOCUMENTEN
Considering the lack of efficient MVA85A vaccination mediated boosting against clinical tuberculosis in infants vaccinated with BCG 41 , this character of
tuberculosis in infected murine lung tissue. Five dormancy genes were selected
Discovery of dormancy associated antigens of Mycobacterium tuberculosis : novel targets for the development of post-exposure or therapeutic tuberculosis vaccines.. Retrieved
Discovery of dormancy associated antigens of Mycobacterium tuberculosis : novel targets for the development of post- exposure or therapeutic tuberculosis vaccines.
Discovery of dormancy associated antigens of Mycobacterium tuberculosis : novel targets for the development of post-exposure or therapeutic tuberculosis vaccines Lin, M.Y...
Discovery of dormancy associated antigens of Mycobacterium tuberculosis : novel targets for the development of post-exposure or therapeutic tuberculosis vaccines Lin, M.Y...
ͳǦʹͲ ͳͳǦ͵Ͳ ʹͳǦͶͲ ͵ͳǦͷͲ ͶͳǦͲ ͷͳǦͲ ͳǦͺͲ ͳǦͻͲ ͺͳǦͳͲͲ ͻͳǦͳͳͲ ͳͲͳǦͳʹͲ ͳͳͳǦͳ͵Ͳ ͳʹͳǦͳͶͲ ͳ͵ͳǦͳͷͲ ͳͶͳǦͳͲ ͳͷͳǦͳͲ ͳͳǦͳͺͲ ͳͳǦͳͻͲ ͳͺͳǦʹͲͲ ͳͻͳǦʹͳͲ
Discovery of dormancy associated antigens of Mycobacterium tuberculosis : novel targets for the development of post-exposure or therapeutic tuberculosis vaccines Lin, M.Y...